Biography
Dr. Ansell’s PhD research at University of Missouri focused on the regulation of gene expression by estrogen receptors. He determined estrogen receptors could regulate the activity of Nrf2, a transcription factor that regulates expression of genes involved in protecting cells from oxidative stress (Mol Cell Endocrinol 2005, Endocrinology 2004). As a postdoctoral researcher at Harvard Medical School, he moved on to investigate gene expression, cellular differentiation and proliferation of pituitary tumors. With more than 15 years of industry experience he is leading a team which designs and implements impactful precision medicine strategies across much of AbbVie’s solid tumor pipeline.
